MP High Court: Codeine Commercial Quantity Under NDPS Act, Bail Denied
Case Law

MP High Court: Codeine Commercial Quantity Under NDPS Act, Bail Denied

India·Briefly Analysis⏱️ 5 min read

Summary

  • The Madhya Pradesh High Court denied bail to Amar Yadav, who was accused of possessing 20 bottles of codeine-based cough syrup.
  • The court ruled that the entire weight of the codeine mixture determines commercial quantity, citing Hira Singh v. Union of India.
  • The defense's argument that the syrup was a 'medicinal preparation' was rejected due to the absence of a valid license, referencing Mohd. Sahabuddin v. State of Assam.
  • Hostile independent witnesses were deemed insufficient to discredit the recovery at the bail stage.
  • Yadav faces charges under the NDPS Act and M.P. Drug Control Act, with prior criminal antecedents noted by the prosecution.

Bail Denied in Codeine Cough Syrup Case

The court emphasized that the argument for a product being a 'medicinal preparation' holds no sway without a valid license, especially when dealing with large, unlicensed quantities of codeine-based substances.

The Madhya Pradesh High Court, in a significant ruling, recently denied a second bail application for Amar Yadav, who faces charges under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, and the M.P. Drug Control Act. Justice B. P. Sharma, presiding at Jabalpur, upheld the prosecution's stance that the unlicensed possession of codeine-based cough syrup, even if a medicinal preparation, falls squarely under the NDPS Act, particularly when the quantity involved is deemed commercial.

Yadav was apprehended on April 27, 2026, in Satna, following police intelligence suggesting he was distributing cough syrup for sale. Authorities allegedly recovered 20 bottles of Onrex cough syrup, each containing 100 ml of codeine phosphate, near the Jamuna Colony ground. The case, registered as Crime No. 399/2026 at Police Station City Kotwali, has since seen a charge-sheet filed against Yadav. His initial bail request had been withdrawn on July 23, 2026, leading to this subsequent application filed under Section 483 of the Bharatiya Nagarik Suraksha Sanhita, 2023, which corresponds to Section 439 of the Criminal Procedure Code.

Defense Challenges and Prosecution's Rebuttal

Advocate Smita Varma, representing Amar Yadav, contended that her client was falsely implicated and that no recovery was made from him. She highlighted that the two independent seizure witnesses, Dheerendra Sen and Suneet Jaiswal, had turned hostile, disavowing any recovery in their presence. Furthermore, the defense argued that the search procedure was flawed, citing non-compliance with Section 105 of the Bharatiya Nagarik Suraksha Sanhita regarding audio-video recording and improper adherence to Section 52-A of the NDPS Act. A central pillar of the defense was the assertion that the syrup constituted a medicinal preparation, thus falling outside the purview of the NDPS Act, and that, in any event, the quantity was not commercial. To support the bail application, several Supreme Court rulings, including those in Jagdish, Dilip, and Sanjeet Kumar Singh, along with Delhi and Patna High Court orders concerning Onrex cases, were presented.

Conversely, panel lawyer N.S. Solanki, arguing for the prosecution, maintained that the 20 bottles recovered amounted to a commercial quantity. He emphasized Yadav's lack of a valid license for possessing such a substance and asserted that hostile independent witnesses alone could not dismantle the prosecution's case at the bail stage. Solanki also brought to the court's attention Yadav's four prior criminal antecedents, which included previous cases under the NDPS Act and the Drugs and Cosmetics Act, invoking the stringent bar on bail stipulated by Section 37 of the NDPS Act.

Defining Commercial Quantity for Codeine

The High Court meticulously addressed the contention regarding the quantity of the seized substance. Relying on Note 4 of the 2001 notification, which was incorporated in 2009, the court clarified that the entire weight of the mixture or preparation, and not merely the isolated narcotic content, is to be considered when determining the quantity. This interpretation aligns with the Supreme Court's definitive pronouncement in the case of Hira Singh v. Union of India, which established this principle for NDPS cases involving mixtures.

Following this established legal precedent, the court unequivocally stated that the entire weight of the mixture or preparation, rather than solely the narcotic content, must be considered when determining if a commercial quantity of codeine-based syrup is involved. Consequently, the court concluded that the recovery of 20 bottles of Onrex cough syrup from Amar Yadav indeed constituted a commercial quantity under the NDPS Act, thereby strengthening the prosecution's case against his bail application.

Medicinal Preparation Defense and Bail Implications

Regarding the defense's argument that the syrup was a 'medicinal preparation,' the bench found this claim to be without merit given the specific facts of the case. Citing the Supreme Court's decision in Mohd. Sahabuddin v. State of Assam, the court reiterated that the unlicensed handling of substantial quantities of codeine-based syrup attracts the provisions of the NDPS Act and cannot be exempted simply because the product is a pharmaceutical preparation. The court further referenced a Calcutta High Court ruling concerning Phensedyl syrup, reinforcing the necessity of proper authorization.

The court emphasized that Amar Yadav was not a license holder and failed to produce any valid documentation to justify his possession of the cough syrup. The precedents cited by the applicant were deemed distinguishable on their facts, making them inapplicable to the current situation. Furthermore, the court observed that the recovery could not be dismissed at the bail stage solely based on hostile witnesses, as the remaining prosecution evidence still needed to be examined. This ruling underscores that the 'medicinal preparation' defense is invalid without a proper license, setting a stringent precedent for bail applications in similar cases involving codeine cough syrup commercial quantity within the jurisdiction, making it significantly harder to secure bail for unlicensed possession of such substances.

Practical Implications

Lawyers defending clients accused of NDPS violations involving pharmaceutical preparations must note this ruling from the Madhya Pradesh High Court, which reinforces that the entire weight of a codeine-based mixture determines commercial quantity and that a 'medicinal preparation' defense is invalid without a proper license. This decision sets a precedent for bail applications in similar cases within the jurisdiction, making it harder to secure bail for unlicensed possession of such substances.

Source

Source: Original reporting via Live Law

Get Deeper AI analysis

How does this affect you?

Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.

Finish Reading the Full Story and the Expert Analysis.

Get the latest legal & regulatory intelligence in India

Instant access to full analysis, cited statutes & expert commentary
Customize your dashboard to track what matters to your business operations

Already have an account? Log in

Wansom is AI and can make mistakes.